Patents by Inventor Kenneth H. Jung

Kenneth H. Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9097729
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: August 4, 2015
    Assignee: AMGEN INC.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Publication number: 20150051091
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Application
    Filed: July 26, 2011
    Publication date: February 19, 2015
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Patent number: 7985559
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: July 26, 2011
    Assignee: AMGEN Inc.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Publication number: 20090123937
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Application
    Filed: October 17, 2008
    Publication date: May 14, 2009
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary E. Elliott, Robert Radinsky